News
A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle cell, while also proving beyond doubt that chemical tags on DNA—often ...
CRISPR Therapeutics advances with promising CTX310 data and key clinical milestones ahead. Click here to read an analysis of CRSP stock now.
Mars partners with Pairwise to use CRISPR tech for developing disease- and climate-resilient cacao, aiming to secure future cocoa supply.
Precise and targeted DNA editing by small point mutations as well as the integration of whole genes via CRISPR/Cas technology has great potential for applications in biotechnology and gene therapy.
UCSF is the first university to certify medical students as bedside assistants for robotic surgeries, giving the next generation of surgeons a head start in a burgeoning field.
CRISPR-GPT Turns Novice Scientists into Gene Editing Experts A large language model can design and troubleshoot CRISPR protocols from scratch, allowing first-time researchers to achieve up to 90 ...
Hosted on MSN25d
Crispr Therapeutics’ CTX112 Study: A Promising Step in ... - MSN
Study Overview: The clinical study titled ‘A Phase 1 Dose Evaluation Study of the Safety and Preliminary Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results